Clearstead Advisors
BIOA icon

Clearstead Advisors’s BioAge Labs BIOA Stock Holding History

Clearstead Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8 Buy
+1
New +$14 ﹤0.01% 3488
2025
Q4 		– Sell
-18
Closed -$106 – 3309
2025
Q3 		$106 Hold
18
– – ﹤0.01% 2927
2025
Q2 		$75 Buy
+18
New +$73 ﹤0.01% 2643

Other funds holding BIOA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Mizuho Securities USA
Mizuho Securities USA New York $6.3B AUM 30.7% 1-Year Est. Return
Alessandra Capital Management
Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return

Clearstead Advisors's BIOA Position: Q3 2026 in Review

Clearstead Advisors opened a new position in BioAge Labs (BIOA) in Q3 2026: 1 share worth $8. The stake represents ﹤0.01% of the portfolio and ranks #3488 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in BIOA as recently as Q3 2025.

Clearstead Advisors first reported a position in BIOA in Q2 2025 and has held it in 3 quarters since. The position peaked at $106 in Q3 2025. 54 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Clearstead Advisors held 1 share of BioAge Labs worth $8 as of Q3 2026.
  • BioAge Labs was a new Clearstead Advisors position in Q3 2026.
  • BioAge Labs made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #3488 holding.
  • Clearstead Advisors first reported a position in BioAge Labs in Q2 2025 and has held it in 3 quarters since.
  • Clearstead Advisors's BioAge Labs position peaked at $106 in Q3 2025.
  • 54 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.